UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling

Cell death and differentiation, 2020-05, Vol.27 (5), p.1709-1727

2020

Volltextzugriff (PDF)

Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression

Oncogene, 2020-01, Vol.39 (2), p.293-307

2020

Volltextzugriff (PDF)

Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2

Molecular cancer, 2017-01, Vol.16 (1), p.5-5, Article 5

2017

Volltextzugriff (PDF)

ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2021-01, Vol.70 (1), p.137-151

2021

Volltextzugriff (PDF)

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7

Biochemical and biophysical research communications, 2010-01, Vol.391 (3), p.1483-1489

2010

Volltextzugriff (PDF)

Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100

European journal of cancer (1990), 2014-05, Vol.50 (8), p.1541-1554

2014

Volltextzugriff (PDF)

A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer

Frontiers in oncology, 2022-09, Vol.12, p.905222-905222

2022

Volltextzugriff (PDF)

A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients

Molecular cancer, 2017-10, Vol.16 (1), p.162-162, Article 162

2017

Volltextzugriff (PDF)

Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy

Clinical cancer research, 2018-02, Vol.24 (4), p.950-962

2018

Volltextzugriff (PDF)

Correction: Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2

Molecular cancer, 2024-05, Vol.23 (1), p.112-112, Article 112

2024

Volltextzugriff (PDF)

Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1‐mediated SOX2 methylation

Cancer science, 2023-03, Vol.114 (3), p.921-936

2023

Volltextzugriff (PDF)

miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

International journal of experimental pathology, 2015-08, Vol.96 (4), p.240-247

2015

Volltextzugriff (PDF)

New insights into long non-coding RNAs in non-small cell lung cancer

Biomedicine & pharmacotherapy, 2020-11, Vol.131, p.110775-110775, Article 110775

2020

Volltextzugriff (PDF)

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

European journal of cancer (1990), 2010-06, Vol.46 (9), p.1692-1702

2010

Volltextzugriff (PDF)

Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway

Molecular cancer, 2015-03, Vol.14 (1), p.59-59, Article 59

2015

Volltextzugriff (PDF)

MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1)

European journal of cancer (1990), 2013-02, Vol.49 (3), p.710-724

2013

Volltextzugriff (PDF)

Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop

Molecular and Cellular Biology, 2012-08, Vol.32 (15), p.3121-3131

2012

Volltextzugriff (PDF)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors

Frontiers in pharmacology, 2020-08, Vol.11, p.1213-1213

2020

Volltextzugriff (PDF)

KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer

Molecular and cellular biochemistry, 2016-11, Vol.422 (1-2), p.61-74

2016

Volltextzugriff (PDF)

MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer

Frontiers in pharmacology, 2021-04, Vol.12, p.625593-625593

2021

Volltextzugriff (PDF)

Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma

Frontiers in immunology, 2022-07, Vol.13, p.923194-923194

2022

Volltextzugriff (PDF)

EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway

Tumor biology, 2016-09, Vol.37 (9), p.11959-11971

2016

Volltextzugriff (PDF)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new

Frontiers in immunology, 2023-01, Vol.13, p.1129623-1129623

2023

Volltextzugriff (PDF)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors

Frontiers in pharmacology, 2021-06, Vol.12, p.645862-645862

2021

Volltextzugriff (PDF)

N‐acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial–mesenchymal transition

The FEBS journal, 2015-11, Vol.282 (22), p.4295-4306

2015

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(128)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(89)
Humans
(68)
Oncology
(45)
Cell Line, Tumor
(38)
Male
(31)
Female
(28)
Lung Cancer
(27)
Lung Neoplasms - Genetics
(27)
Animals
(26)
Lung Neoplasms - Pathology
(25)
Small Cell Lung Carcinoma - Genetics
(25)
Prognosis
(22)
Middle Aged
(20)
Small Cell Lung Cancer
(20)
Apoptosis
(19)
Gene Expression Regulation, Neoplastic
(19)
Lung Neoplasms - Drug Therapy
(19)
Lung Neoplasms - Metabolism
(19)
Small Cell Lung Carcinoma - Pathology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling

Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression

Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2

ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7

Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100

A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer

A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients

Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy

Correction: Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2

Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1‐mediated SOX2 methylation

miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

New insights into long non-coding RNAs in non-small cell lung cancer

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway

MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1)

Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors

KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer

MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer

Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma

EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway

Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors

N‐acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial–mesenchymal transition

Suchergebnisse filtern